Medipharm Labs Corp
TSX:LABS

Watchlist Manager
Medipharm Labs Corp Logo
Medipharm Labs Corp
TSX:LABS
Watchlist
Price: 0.07 CAD 7.69%
Market Cap: 29.5m CAD

P/E
Price to Earnings

-3.7
Current
-2.3
Median
21.6
Industry
Lower than median
Lower than industry value

The Price to Earnings (P/E) ratio shows how much investors are willing to pay for each dollar of a company’s earnings. It’s calculated by dividing the company’s market value by its net income.

P/E
-3.7
=
Market Cap
29.5m CAD
/
Net Income
-8m CAD
All Countries
Close
Earnings Growth PEG
CA
Medipharm Labs Corp
TSX:LABS
Average P/E: 23.7
Negative Multiple: -3.7
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
54.1
53%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
20
29%
0.7
CH
Roche Holding AG
SIX:ROG
26.8
29%
0.9
UK
AstraZeneca PLC
LSE:AZN
30.2
38%
0.8
CH
Novartis AG
SIX:NOVN
18.1
17%
1.1
US
Merck & Co Inc
NYSE:MRK
12.8
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
13.2
4%
3.3
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -71.5 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.5
29%
0.5

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
hidden
2-Years Forward
P/E
hidden
3-Years Forward
P/E
N/A